SYNTHACE
Synthace is a digital experiment platform built for life science R&D teams to help them run more powerful experiments. It digitizes experiments from end to end: with minimal training, scientists can design and plan reproducible experiments, simulate them ahead of time, run them on their automation equipment, and automatically structure all of their experimental data and metadata in a single place. Controlled from a browser window and needing no code to operate, it makes experiments easier to run in the lab, increases the scientific value of experiments, and also makes it possible to run experiments that were previously thought impossible.
SYNTHACE
Industry:
Biotechnology Industrial Automation Life Science Pharmaceutical Software
Founded:
2011-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.synthace.com
Total Employee:
51+
Status:
Active
Contact:
+44 (0) 20 3976 7676
Total Funding:
80.98 M USD
Technology used in webpage:
Domain Not Resolving DNSSEC Mobile Non Scaleable Content Cloudflare JS U.S. Server Location Visa Google Cloud CDN Google Cloud Global Multi-Region Fastly Fastly Hosted
Similar Organizations
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
BioVersys
BioVersys is a privately held Swiss biopharmaceutical company.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
nference
nference is an Artificial Intelligence (AI)-powered venture creation engine
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Board_member
2011-01-01
Current Employees Featured
Markus Gershater CSO & Co-founder @ Synthace
CSO & Co-founder
2011-03-01
Michael Sadowski Head of Bioinformatics @ Synthace
Head of Bioinformatics
2012-09-01
Guy Levy-Yurista CEO @ Synthace
CEO
2021-05-01
Sybil Wong Director, Marketing & Strategic Partnerships @ Synthace
Director, Marketing & Strategic Partnerships
2019-05-01
Founder
Investors List
Horizons Ventures
Horizons Ventures investment in Series C - Synthace
SOSV
SOSV investment in Series C - Synthace
Sofinnova Partners
Sofinnova Partners investment in Series C - Synthace
SOSV
SOSV investment in Convertible Note - Synthace
SOSV
SOSV investment in Venture Round - Synthace
SOSV
SOSV investment in Series B - Synthace
Horizons Ventures
Horizons Ventures investment in Series B - Synthace
Luminous Ventures
Luminous Ventures investment in Series B - Synthace
SOSV
SOSV investment in Series A - Synthace
Future Planet Capital
Future Planet Capital investment in Series A - Synthace
Key Employee Changes
| Date | New article |
|---|---|
| 2021-03-09 | Synthace Appoints Dr. Nick Jurascheck as VP of Engineering |
Official Site Inspections
http://www.synthace.com Semrush global rank: 2.9 M Semrush visits lastest month: 5.83 K
- Host name: 199.60.103.166
- IP address: 199.60.103.166
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Synthace"
Synthace - Crunchbase Company Profile & Funding
Synthace is a digital experiment platform built for life science R&D teams to help them run more powerful experiments. It digitizes experiments from end to end: …See details»
Synthace: Software + Expertise for Discovery Biology Teams
Synthace’s specialists have spent 20+ years building expertise and software for running the most effective experiments in assay development.See details»
Synthace Leadership: Driving R&D Transformation for …
Synthace's Director of Science Nuno Leitão is a bioengineer, turned molecular biologist, turned automation and DOE specialist, with a real passion for leading teams that build tools for enabling better science, for scientists.See details»
About Synthace, the DOE & Digital Experiment Platform for …
About Synthace, helping biologists design more powerful experiments and DOE without coding.See details»
Synthace - Funding, Financials, Valuation & Investors
Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.See details»
Synthace 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Synthace. Use the PitchBook Platform to explore the full profile.See details»
Synthace Company Profile - Office Locations, Competitors ... - Craft
Synthace has 5 employees across 3 locations, $41.82 m in total funding, and £1.34 m in annual revenue in FY 2022. See insights on Synthace including office locations, competitors, revenue, …See details»
Synthace - Updates, News, Events, Signals & Triggers
Synthace, a SaaS Life Sciences R&D Digital Experiment Platform, announced the appointment of a new Chairman and a new board member. These leadership changes aim to strengthen the …See details»
Synthace - The Org
Synthace's goal is to raise universal bioscience productivity, enabling people to better engineer biology for health, food, energy and manufacturing. Central to its technology is Antha, an …See details»
Synthace - Create more robust assays and accelerate drug …
Synthace is a specialized software platform that helps drug discovery teams optimize their experimental processes through automation and multivariate methods, supported by expert …See details»
How Synthace Works: Design of Experiments for …
Abstract the experiment design and planning process, control lab equipment, and aggregate your data - all in one platform.See details»
Synthace - PharmaSource
Synthace is a leading software company in life sciences, specialising in providing a digital experiment platform for research and development teams. Their innovative technology allows …See details»
Meet The Startup Revolutionizing The Language Of Biology
Jul 17, 2019 London-based startup Synthace is on a mission not just to digitize the lab, but to revolutionize the way biology is done with one simple idea: a universal language. With their …See details»
Synthace - Products, Competitors, Financials, Employees, …
Synthace 's Products & Differentiators Synthace DOE Synthace DOE is an adaptive Design of Experiments (DOE) solution, providing scientists with the ability to quickly and easily define, …See details»
Mission, Vision & Core Values of Synthace
Dec 19, 2024 Synthace is a cutting-edge biotechnology company with a clear mission, vision, and core values that guide their innovative work in the field. Their mission is to revolutionize …See details»
Synthace Raises $35M to Help Scientists to Innovate Faster
Jan 24, 2025 “Synthace’s R&D cloud platform is helping life scientists completely change the way they develop new cures and therapeutics to solve humanity’s most pressing problems,” …See details»
Applications for the Synthace Digital Experiment Platform
Use Synthace to plan experiments, create workflows, gather structured data, and run no-code automation in applications across your organization.See details»
Synthace Raises $35M to Expand Access to Its Revolutionary R&D ...
Nov 16, 2021 “Synthace’s R&D cloud platform is helping life scientists completely change the way they develop new cures and therapeutics to solve humanity’s most pressing problems,” …See details»
Synthace CEO on Scaling Innovative Companies and Accelerating …
Jun 13, 2021 In May 2021, Synthace appointed Guy Levy-Yurista as Chief Executive Officer (CEO) and a member of the Board of Directors. Guy will be leading Synthace through its next …See details»
Synthace, a Digital Experiment Platform for Life Science R&D, …
Apr 5, 2023 Today, Synthace, a digital life science experiment platform, announces it has had its most successful year on record with major adoption and expansionSee details»